STCube, Inc. (KOSDAQ:052020)

South Korea flag South Korea · Delayed Price · Currency is KRW
20,500
+200 (0.99%)
Apr 28, 2026, 3:30 PM KST
217.34%
Market Cap 1.39T
Revenue (ttm) 6.98B
Net Income (ttm) -21.80B
Shares Out 67.93M
EPS (ttm) -321.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 600,856
Average Volume 523,815
Open 20,200
Previous Close 20,300
Day's Range 19,540 - 21,450
52-Week Range 5,500 - 21,300
Beta -0.82
RSI 73.13
Earnings Date May 14, 2026

About STCube

STCube, Inc., a biopharmaceutical company, develops medicines in South Korea. The company develops anti-cancer immunotherapeutic drugs and anti-viral drugs. It offers platform technologies, which include In vivo RNAi ICP target discovery platform for exploring material ICP target; glycosylation-specific antibody development platform for development of antibodies that mask glycosylation sites on target proteins; and ICP functional assay platform for development of various in vivo/in vitro analytical/experimental methods. The company’s product pi... [Read more]

Industry Technology Distributors
Sector Technology
Founded 1989
Employees 13
Stock Exchange KOSDAQ
Ticker Symbol 052020
Full Company Profile

Financial Performance

In 2025, STCube's revenue was 6.98 billion, a decrease of -38.18% compared to the previous year's 11.30 billion. Losses were -21.80 billion, 1.69% more than in 2024.

Financial Statements

News

There is no news available yet.